ArticleDigestive diseases and sciences2021

Vedolizumab Dose Escalation Improves Therapeutic Response in a Subset of Patients with Ulcerative Colitis.

Courtney Perry et al.PubMed ↗Publisher ↗

No numbers read from the abstract.